ISR
ISR Real Time Price USDRecent trades of ISR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ISR's directors and management
Government lobbying spending instances
-
$22,500 Apr 15, 2022 Issue: Health Issues
-
$22,500 Jan 31, 2022 Issue: Health Issues
-
$7,000 Nov 02, 2021 Issue: Health Issues
-
$20,000 Sep 16, 2021 Issue: Medicare/Medicaid
-
$20,000 Jul 16, 2021 Issue: Medicare/Medicaid
-
$20,000 Apr 19, 2021 Issue: Medicare/Medicaid
-
$20,000 Jan 13, 2021 Issue: Medicare/Medicaid
-
$20,000 Oct 19, 2020 Issue: Medicare/Medicaid
-
$20,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$20,000 Apr 16, 2020 Issue: Medicare/Medicaid
-
$20,000 Jul 11, 2019 Issue: Medicare/Medicaid
-
$20,000 Apr 08, 2019 Issue: Medicare/Medicaid
-
$20,000 Jan 16, 2019 Issue: Medicare/Medicaid
-
$20,000 Jul 11, 2018 Issue: Medicare/Medicaid
-
$10,000 Apr 12, 2018 Issue: Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ISR in WallStreetBets Daily Discussion
Recent insights relating to ISR
Recent picks made for ISR stock on CNBC
ETFs with the largest estimated holdings in ISR
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ISR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.